Orchestra BioMed Holdings, Inc. Capital Expenditures Incurred but Not yet Paid
Orchestra BioMed Holdings, Inc. (OBIO) reported Capital Expenditures Incurred but Not yet Paid of $78.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-08-10
- Orchestra BioMed Holdings, Inc. capital expenditures incurred but not yet paid for the quarter ending 2026-06-30 was $39.00K.
- Orchestra BioMed Holdings, Inc. capital expenditures incurred but not yet paid for the quarter ending 2026-03-31 was $39.00K.
- Orchestra BioMed Holdings, Inc. capital expenditures incurred but not yet paid for the quarter ending 2025-12-31 was $87.00K.
- Orchestra BioMed Holdings, Inc. capital expenditures incurred but not yet paid for the quarter ending 2025-09-30 was $59.00K.
- Orchestra BioMed Holdings, Inc. capital expenditures incurred but not yet paid for fiscal 2025 was $169.00K.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|---|
| 2026-06-30 | $39.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $78.00K 10-Q · filed 2026-08-10 | $165.00K derived: sum of 3 quarters · filed 2026-08-10 | $224.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $39.00K 10-Q · filed 2026-05-12 | $126.00K derived: sum of 2 quarters · filed 2026-05-12 | $185.00K derived: sum of 3 quarters · filed 2026-05-12 | |
| 2025-12-31 | $87.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $146.00K derived: sum of 2 quarters · filed 2026-03-12 | $169.00K 10-K · filed 2026-03-12 | |
| 2025-09-30 | $59.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $82.00K 10-Q · filed 2025-11-10 | ||
| 2025-06-30 | $23.00K 10-Q · filed 2026-08-10 | |||
| 2024-09-30 | $27.00K 10-Q · filed 2025-11-10 | |||
| 2024-03-31 | $107.00K 10-Q · filed 2025-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |